The Italian biotech firm WISE Srl is working on implantable leads for neuromonitoring and brain-machine connections. Now, the company announced that it has raised €15M in its Series C. One of the investors is the Italian single family office of the Rossi Luciani family.
WISE: Medical device company working on implantable leads
WISE is a biotech company based in Milan and Berlin working on implantable Neuromodulation and Neuromonitoring leads. Through WISE’s WCS electrode, intraoperative neuromonitoring is enabled. The now-raised funds are used to develop a novel product the SCS EXPERT. Through SCS, a implantable multi-column paddle lead, Spinal Cord Stimulation (SCS) gets possible. Thereby, chronic pain can be treated. More than 328 million people suffer from chronic pain globally. WISE’s approach offers a treatment way apart from the usually prescribed drugs.
$15M Series C Financing Round: Italian Rossi Luciani Single Family Office (New Frontiers srl) as investor
Many new and existing investors participated in WISE’s recent funding round. New investors include CDP Venture Capital, Indaco Ventures as well as EUREKA! Venture. Also, the European Commision granted the company €2.3M earlier this year. Amongst the existing investors is New Frontier srl, which is an investment vehicle of the Rossi Luciani family office. New Frontier is focused on startups, especially in the biotech sphere. The Rossi Luciani family is the majority shareholder of listed electrical device company Carel Industries SpA.
Relevant family office articles
- Hamburg Single Family Office Invests In Online Bike Shop
- Single Family Office from Missouri invests in Sharpen Technologies $12M Growth Round
- Vienna Single Family Office Acquires Luxembourg Private Bank FIS
You also might like researchgermany.com’s whitepaper about B2B sales in Germany.